India’s Hepatitis B Virus Drug Market Will Grow Ten-Fold by 2012
By Frontier India Pharmacetuicals News | August 18th, 2008 | Category: Asia Medical News | No Comments »Decision Resources, one of the world’s leading research and advisory firms focusing on pharmaceutical and healthcare issues, forecasts that the Indian hepatitis B virus drug market will grow ten-fold by 2012, from $1.7 million in 2007 to $17 million in 2012. According to the new Emerging Markets report entitled Hepatitis B Virus in India, this [...]


